Patients with symptomatic (New York Heart Association [NYHA] class III or IV) systolic (left ventricular ejection fraction [LVEF] ≤40%) congestive heart failure (CHF) were randomized to ...
Explore how deep learning enables automated extraction of NYHA classes and heart failure symptoms, enhancing heart failure ...
In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, ...
Additionally, 92% of patients either improved or maintained their New York Heart Association (NYHA) class, a key metric for ...
The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.
USA: The REALIZE-K trial shows that a daily oral potassium binder can safely enable the use of mineralocorticoid receptor ...
Medpage Today on MSN12d
Novel CRISPR-Cas9-Based Promising in ATTR CardiomyopathyA CRISPR-Cas9-based investigational therapy was linked with a drop in serum transthyretin (TTR) levels in patients with ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
6.0%), NYHA class (10.2% vs ... control group with respect to the annualized rate of hospitalization for heart failure (9.7% vs. 10.0%). Severe bleeding occurred in 15.4% of the valve-replacement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback